Table 1 Baseline characteristics of ILD-group
CTD | Myositis | Vasculitis | RA | |
|---|---|---|---|---|
Number of patients | N = 46 | N = 12 | N = 10 | N = 6 |
Age mean ± standard deviation | 62.1 ± 14.5 years | 60.1 ± 9.7 years | 61.7 ± 10.7 years | 63.0 ± 10.9 years |
Gender | Women N = 42 (91.3%) Men N = 4 (8.7%) | Women N = 8 (66.7%) Men N = 4 (33.3%) | Women N = 6 (60%) Men N = 4 (40%) | Women N = 5 (83.3%) Men N = 1 (16.7%) |
IRD | SLE: N = 9 Sjogren´s disease: N = 7 SSc: N = 25 MCTD: N = 5 | Dermatomyositis: N = 5 Polymyositis: N = 1 Anti Jo1-syndrome: N = 6 | EGPA: N = 5 GPA: N = 2 MPA: N = 3 | N = 6 |
Immunological laboratory findings | ANA positive: N = 46 Scl 70-antibody positive: N = 13 Ro-antibody positive: N = 8 dsDNS-antibody positive: N = 7 Centromer-antibody positive: N = 5 U1RNP-antibody positive: N = 4 PM-Scl-antibody positive: N = 2 Tif1g-antibody positive: N = 1 | ANA positive: N = 7 Anti Jo1-antibody positive: N = 6 MDA5-antibody positive: N = 2 PL-12-antibody positive: N = 1 PL-7-antibody positive: N = 1 | MPO-antibody positive: N = 3 PR3-antibody positive: N = 2 | Anti-CCP-antibody positive: N = 5 RF-positive: N = 4 |